Using targeted lipid nanoparticles to deliver chemotherapeutic agents against pancreatic cancer
Ended Project Grant Awarded Last action
- Award ID
- R41CA247009
- Recipient
-
Doricpharma LLC UEI PFYTQA2WAZS7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $557,661
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Funding
-
- $505,660.59 Federal
- $52,000.00 Non-federal
- Place of performance
- Upland, CA 91784, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$93 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $52,000 | $0 | |
| Amendment | $52,000 | $52,000 | |
| Amendment | $102,195 | $0 | |
| Original award | $299,559 | $0 |
Show all 11
Quick answers
Who received award R41CA247009?
R41CA247009 was awarded to Doricpharma LLC by National Cancer Institute (National Institutes of Health) on March 5, 2020.
How much is award R41CA247009 worth?
$557,661 has been obligated on R41CA247009: $505,661 in federal funding and $52,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award